Major relief to patients: Cardiac stents to cost 75% less now
Advertisement
Advertisement
Major life-saving devices cannot be used to earn profit. The National Pharmaceutical Pricing Authority on February 14 slashed stent prices by over 75%. Including VAT, drug eluting stents (DES) and bioresorbable vascular scaffolds (BVS) will now only cost heart patients Rs 31,080, while bare metal stents (BMS) would cost Rs 7,623.Earlier private hospitals were earning major profits from these stents. The decision is expected to break the nexus between manufacturers, doctors and hospitals that have led to "unethical" markups in the prices of these stents, according to The Economic Times.
"In short, the Authority noted that there is no value addition or financial stakes in trade at the level of hospitals and that maximum price distortion and hike takes place at that level," NPPA chairman Bhupendra Singh told ET. "Legally as well as ethically, hospitals cannot and should not charge margins," he added.
According to data from the drug pricing regulator, hospitals were found earning exorbitant margins on stents-over 650% in some cases.
Advertisement
Advertisement
- 2 states where home prices are falling because there are too many houses and not enough buyers
- US buys 81 Soviet-era combat aircraft from Russia's ally costing on average less than $20,000 each, report says
- A couple accidentally shipped their cat in an Amazon return package. It arrived safely 6 days later, hundreds of miles away.
- 9 health benefits of drinking sugarcane juice in summer
- 10 benefits of incorporating almond oil into your daily diet
- From heart health to detoxification: 10 reasons to eat beetroot
- Why did a NASA spacecraft suddenly start talking gibberish after more than 45 years of operation? What fixed it?
- ICICI Bank shares climb nearly 5% after Q4 earnings; mcap soars by ₹36,555.4 crore